Cargando…
Reply to Mahler et al.: Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
Autores principales: | Nici, Linda, Aaron, Shawn D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667900/ https://www.ncbi.nlm.nih.gov/pubmed/32791006 http://dx.doi.org/10.1164/rccm.202006-2375LE |
Ejemplares similares
-
Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Mahler, Donald A., et al.
Publicado: (2020) -
Reply to Mahler: Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Wu, Ann Chen, et al.
Publicado: (2019) -
Reply to Prieto-Centurion et al.: Patients with Chronic Obstructive Pulmonary Disease Require More Than Pulmonary Rehabilitation to Improve Outcomes
por: Nici, Linda, et al.
Publicado: (2019) -
Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
por: Mammen, Manoj J., et al.
Publicado: (2021) -
Reply to Chase et al. and to Milner et al.
por: Mittel, Aaron M., et al.
Publicado: (2020)